Phospholipid composition and kinetics in different endobronchial fractions from healthy volunteers

BMC Pulmonary Medicine

Anthony D Postle²  Michael PW Grocott¹  Rebecca Cusack¹  Victoria Goss²  Ahilanandan Dushianthan¹ 

[1] Anaesthesia and Critical Care Research Unit, CE 93, MP24, E-Level, Centre Block, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK;Integrative Physiology and Critical Illness Group, Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK

关键词: Mass spectrometry;    Isotope labelling;    Stable isotopes;    Deuteriated choline;    Phosphatidylcholine;    Surfactant;   

Others  :  865441
DOI  :  10.1186/1471-2466-14-10

 received in 2013-06-27, accepted in 2014-01-30,  发布年份 2014

【 摘 要 】

Background

Alterations in surfactant phospholipid compositions are a recognized feature of many acute and chronic lung diseases. Investigation of underlying mechanisms requires assessment of surfactant phospholipid molecular composition and kinetics of synthesis and turnover. Such studies have recently become possible in humans due to the development of stable isotope labelling combined with advances in analytical methods in lipidomics. The objectives of this study are to compare phospholipid molecular species composition and phosphatidylcholine synthesis and turnover in surfactant isolated from various endobronchial compartments in healthy adults.

Methods

Healthy adults (N = 10) were infused with methyl-D₉-choline chloride and samples of induced sputum, tracheal wash and small volume bronchoalveolar lavage fluid were obtained subsequently at intervals up to 96 hours. Surfactant phospholipid composition and incorporation of stable isotope into surfactant phosphatidylcholine were determined by electrospray ionisation mass spectrometry.

Results

While molecular species compositions of phospholipids were similar for all three sample types, dipalmitoylphosphatidylcholine content was highest in lavage, intermediate in tracheal wash and lowest in sputum. Methyl-D₉-choline incorporation into surfactant phosphatidylcholine was lower for sputum at 24 hours but reached equilibrium with other sample types by 48 hours. Fractional methyl-D₉-dipalmitoylphosphatidylcholine incorporation for all sample types was about 0.5% of the endogenous composition. Lysophosphatidylcholine enrichment was twice than that of phosphatidylcholine.

Conclusions

Tracheal secretions may be of value as a surrogate to assess bronchoalveolar lavage fluid surfactant molecular composition and metabolism in healthy people. Despite minor differences, the phospholipid molecular composition of induced sputum also showed similarities to that of bronchoalveolar lavage fluid. Detailed analysis of newly synthesized individual phosphatidylcholine species provided novel insights into mechanisms of surfactant synthesis and acyl remodelling. Lysophosphatidylcholine methyl-D₉ incorporation patterns suggest that these species are secreted together with other surfactant phospholipids and are not generated in the air spaces by hydrolysis of secreted surfactant phosphatidylcholine. Application into patient populations may elucidate potential underlying pathophysiological mechanisms that lead to surfactant alterations in disease states.

【 授权许可】

   
2014 Dushianthan et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Griese M: Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 1999, 13:1455-1476.
• [2]Dushianthan A, Cusack R, Goss V, Postle AD, Grocott MP: Clinical review: exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome - where do we go from here? Crit Care 2012, 16:238. BioMed Central Full Text
• [3]Haslam PL: Bronchoalveolar lavage studies of pulmonary surfactant. Arch Bronconeumol 1994, 30:207-211.
• [4]Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L: Evidence of lung surfactant abnormality in respiratory failure: study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest 1982, 70:673-683.
• [5]Günther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, Seeger W: Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 1996, 153:176-184.
• [6]Bernhard W, Pynn CJ, Jaworski A, Rau GA, Hohlfeld JM, Freihorst J, Poets CF, Stoll D, Postle AD: Mass spectrometric analysis of surfactant metabolism in human volunteers using deuteriated choline. Am J Respir Crit Care Med 2004, 170:54-58.
• [7]Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanović R, Maestrelli P, Sterk PJ: Sputum induction. Eur Respir J Suppl 2002, 37:3s-8s.
• [8]Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.
• [9]Postle AD, Heeley EL, Wilton DC: A comparison of the molecular species compositions of mammalian lung surfactant phospholipids. Comp Biochem Physiol A Mol Integr Physiol 2001, 129:65-73.
• [10]Wright SM, Hockey PM, Enhorning G, Strong P, Reid KB, Holgate ST, Djukanovic R, Postle AD: Altered airway surfactant phospholipid composition and reduced lung function in asthma. J Appl Physiol 2000, 89:1283-1292.
• [11]Batenburg JJ: Surfactant phospholipids: synthesis and storage. Am J Physiol 1992, 262:L367-L385.
• [12]Bunt JE, Zimmermann LJ, Wattimena JL, van Beek RH, Sauer PJ, Carnielli VP: Endogenous surfactant turnover in preterm infants measured with stable isotopes. Am J Respir Crit Care Med 1998, 157:810-814.
• [13]Cavicchioli P, Zimmermann LJ, Cogo PE, Badon T, Giordano G, Torresin M, Zacchello F, Carnielli VP: Endogenous surfactant turnover in preterm infants with respiratory distress syndrome studied with stable isotope lipids. Am J Respir Crit Care Med 2001, 163:55-60.
• [14]Cogo PE, Gucciardi A, Traldi U, Hilkert AW, Verlato G, Carnielli V: Measurement of pulmonary surfactant disaturated-phosphatidylcholine synthesis in human infants using deuterium incorporation from body water. J Mass Spectrom 2005, 40:876-881.
• [15]Simonato M, Baritussio A, Ori C, Vedovelli L, Rossi S, Dalla Massara L, Rizzi S, Carnielli VP, Cogo PE: Disaturated-phosphatidylcholine and surfactant protein-B turnover in human acute lung injury and in control patients. Respir Res 2011, 12:36. BioMed Central Full Text
• [16]Hillman NH, Kallapur SG, Pillow JJ, Nitsos I, Polglase GR, Ikegami M, Jobe AH: Inhibitors of inflammation and endogenous surfactant pool size as modulators of lung injury with initiation of ventilation in preterm sheep. Respir Res 2010, 11:151. BioMed Central Full Text
• [17]Goss V, Hunt AN, Postle AD: Regulation of lung surfactant phospholipid synthesis and metabolism. Biochim Biophys Acta 1831, 2013:448-458.
• [18]Meng H, Sun Y, Lu J, Fu S, Meng Z, Scott M, Li Q: Exogenous surfactant may improve oxygenation but not mortality in adult patients with acute lung injury/acute respiratory distress syndrome: a meta-analysis of 9 clinical trials. J Cardiothorac Vasc Anesth 2012, 26:849-856.